MTOR and acute myeloid leukemia: Aberrant phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway has been implicated in AML cells [18, 19] and promotes cell proliferation, growth, and survival.